| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |